A push for equity + global rescheduling of psilocybin
Global Wellness Institute Announces New Initiative on Psychedelics & Healing Major non-profit Global Wellness Institute
March 15, 2022
Global Wellness Institute Announces New Initiative on Psychedelics & Healing Major non-profit Global Wellness Institute
NeonMind Reports Business Highlights on Partnership Activities, Clinical Pipeline and Corporate Developments Almost 40% of
Red Light Holland and Advocacy Group Psychedelic Medicine Alliance Washington Celebrate the Success of their
Psilocybin safer to take with psychiatric medications than MDMA, researchers say An analysis of 40 publications found
Novamind to Conduct Phase II Psilocybin Trial for Major Depressive Disorder Novamind (NM) began a
MindMed Announces Publication of Study Comparing the Acute Effects of Lysergic Acid Diethylamide and Psilocybin
Enveric Biosciences Files Portfolio of Patent Applications for Tryptamine-Based Molecules Robust Portfolio of Psychedelic-Inspired Molecules
Vancouver discovery will make ‘Magic Mushroom’ mental health care cheaper Producing psilocybin is wildly expensive
Filament Health and ATMA Journey Centers Announce Licensing Agreement Filament Health (FH) will license its natural
Recruitment for an upcoming trial – Psilocybin as a Treatment for Anorexia Nervosa: A Pilot
Mindset Pharma Identifies New Pharmacological Insights of First Generation Psychedelics Through its COPE Program with
Mydecine Announces MYCO-005 Family of Improved Safety Microdose Novel Molecules One of the few concerns
Nova Mentis Study Confirms Oral Microdose Psilocybin Treatment of Autism Vancouver, British Columbia – February 16,
Optimi Health Approved to Supply Psilocybin Under Health Canada’s Special Access Program VANCOUVER, BC (GLOBE
Psychedelic therapy for depression still effective one year later Johns Hopkins researchers followed up with
Psilocybin use associated with lowered odds of having been arrested, study finds People who use
Nova Mentis Study Confirms Oral Microdose Psilocybin Treatment of Autism This week, Nova Mentis (NOVA)
Hawaii Senators Approve Psilocybin Task Force Bill In Committee, With Decriminalization Measures Still Pending Hawaii
Core One Labs Completes Strategic Acquisition of Awakened Biosciences and its Game-Changing Provisional Patents Vancouver,
Core One Labs’ Successful Patent Application Filing for Protection of its Biosynthetic Production System for
Lawmakers say no to bill legalizing psilocybin-assisted therapy in Maine Maine lawmakers rejected a bill
Mydecine’s Exclusive Dealer Identified as Licensed Psilocybin and MDMA Supplier in Canada Mydecine now able
Optimi Health Dealer’s License Granted by Health Canada Optimi Health (OPTI) received a Dealer’s License from
Psyence Awarded ISO Certification through the British Standards Institute for its Natural Psilocybin Production Facility